Skip to main content

The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World

 


Market Overview:

Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages.

Competitive Landscape:

Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI, Inspirata, Inc., KONFOONG BIOTECH INTERNATIONAL CO., LTD., Glencoe Software, OptraSCAN, Sectra AB, Objective Pathology Services, Indica Labs, Corista, Akoya Biosciences, Aiforia Technologies Oy, Visiopharm A/S, Huron Digital Pathology, XIFIN, Inc., Apollo Enterprise Imaging, 3DHISTECH, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems.

Key Market Drivers:

Increasing developments related to the global digital pathology market are expected to augment the growth of the market, For instance, in September 2021, Visiopharm and Agilent Technologies, Inc. partnered in order to co-market Visiopharm’s CE-IVD marked Artificial Intelligence-driven Precision Pathology software, along with the automated pathology staining solutions of Agilent. Although digital pathology has only just begun to enter the clinical world, it already offers many benefits. Digital pathology tools can help pathologists make faster, more accurate diagnoses. They can also share results with other experts, and they can be shared in educational settings. The increasing expansion of pathology labs in the world is estimated to enhance the growth of the global digital pathology market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global digital pathology market. For instance, in April 2021, Paige.AI, Inc. and Leica Biosystems collaborated on Paige’s AI-enabled research software to aid in grading and tumor detection. 

Key Takeaways:

·         North America is expected to dominate the growth of the global digital pathology market, owing to the recent developments by key players in the region. For instance, in August 2020, Bio-Techne Corporation and Leica Biosystems collaborated in order to automate RNAscope COVID-19 probes on Leica’s BOND RX platform for research purposes.

·         Europe is estimated to witness high growth in the global digital pathology market, owing to the high expansion of key market players in the region. For instance, in August 2021, University Medical Center Utrecht and Sectra AB signed went in a partnership, in order to use Sectra’s pathology module.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin
Post a Comment
Read more

Increasing various research activities is propelling growth of the pediatric vaccines market

  Pediatric Vaccine Market: Global Trends Over the course of the forecast period, rising public awareness of vaccinations and immunisation is anticipated to fuel market expansion for paediatric vaccines worldwide. For instance, the United States recognises January as Cervical Health Awareness Month, promoting the value of routine immunisation and screening in the fight against cancer. Global Pediatric Vaccine Market: Drivers Increasing awareness regarding vaccines and immunization among the populace is expected to boost growth of the global pediatric vaccine market over the forecast period. For instance, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded.
Post a Comment
Read more

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering takes place and which layer of skin is affected. Global epidermolysis bullosa market is estimated to be valued at  US$ 3,
Post a Comment
Read more